Every time I write about vaping and the extraordinary lengths that the tobacco industry (epitomized by Juul, a sister company to Marlboro) has gone to in order to convince children to vape, I hear from people who tell me that vaping is safe, especially compared to smoking.
1/
This month, I wrote "I Quit," about my own smoking cessation, with some of Juul's dirtiest tricks, including increasing the nicotine in its child-targeted fruit flavors and its fake "mental health seminars" in schools where they promote vaping.
"Reporting bias" is when you researchers report on studies (or parts of studies) that support their employers' commercial goals (or their own ideological ones), leaving out the results that are inconclusive or harmful to their cause.
5/
Reporting bias was once endemic to pharma research, to the point where HALF of the human subject studies pharma companies started never reported in.
Imagine a study of coin-tosses where you only reported half the results - you could "prove" that coins ALWAYS came up heads.
6/
One of the most effective fighters against reporting bias is @bengoldacre, whose 2012 book BAD PHARMA documented the practice - and its human cost - in eye-watering detail.
Goldacre went on to help found the Register of All Trials, where every pharma trial is pre-registered in a public repository, allowing regulators to disqualify drugs whose trials don't report in.
The Register of All Trials model has been replicated around the world, including in the US, where the FDA maintains a similar repository. The researchers used this to locate trials registered by Juul Labs and then checked whether and how they'd reported in.
9/
What they found was a classic case of reporting bias. Trials that measured five phenomena might only report back on one or two of them, which supported the safety of vaping (leaving us to assume that the remainder showed vaping to be dangerous).
10/
And, of course, some trials didn't report back at all.
This is deeply unethical.
For one thing, the trial subjects engaged in conduct potentially harmful to their own health in order to further science.
11/
It's bad enough if they were injured in these trials, but if the fact of their injury was suppressed in order to serve Juul's profits, then they were harmed for NOTHING.
12/
The tobacco industry has a long history of bad science, of faking the research on the way its products harm their customers. Juul tells us that its products are safe, but it suppresses significant amounts of its own research.
13/
NOT ONE of the Juul studies the researchers investigated had fully reported in.
Not.
One.
Now, maybe Juul is keeping its research outcomes a secret because it knows we'll be delighted with the results and it doesn't want to spoil the surprise.
ETA - If you'd like an unrolled version of this thread to read or share, here's a link to it on pluralistic.net, my surveillance-free, ad-free, tracker-free blog:
Before covid, "remote proctoring" tools were a niche product, invasive tools that spied on students who needed to take high-stakes tests but couldn't get to campus or a satellite test-taking room. But the lockdown meant that *all* students found themselves in this position.
1/
(If you'd like an unrolled version of this thread to read or share, here's a link to it on pluralistic.net, my surveillance-free, ad-free, tracker-free blog:)
This could have prompted educators to reconsider the use of high-stakes tests. After all, high-stakes testing has well-understood limitations in pedagogy, and organizes education around a highly artificial ritual completely unlike the rest of scholarly *and* industrial life.
3/
I've been paying close attention to @RepThomasMassie during the #ACCESSAct markup and I can't figure out his point. He correctly observes that proprietary standards are anticompetitive, but opposes the gold standard for open standards, namely, an IPR policy requiring licensing
@RepThomasMassie has described himself as a software developer, but it really feels like he is way, way out of his depth on standardization. Has he ever participated in an SDO. Not being able to distinguish between "interop" and "common vuln" is a pretty tyro error.
It's stuff like this that makes people assume that lawmakers are incapable of understanding - and thus regulating - technology. @RepThomasMassie really needs to get up to speed on how standards work.
In the #ACCESSAct hearing, @RepThomasMassie called the shared vulnerabilities in large-scale hacks as stemming from "interoperability." That's factually wrong. They have "shared dependencies" (use the same code/modules). This isn't the same thing as "interoperability."
Then @RepThomasMassie correctly warned that when firms get to define standards to their proprietary advantage, it produces monopoly power. However, #ACCESSAct provides for OPEN standards, developed independently of large firms.
The problem of proprietary advantage through capture of standards is well-understood and the #ACCESSAct takes account of it.